These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Stem cell features of benign and malignant prostate epithelial cells. De Marzo AM, Nelson WG, Meeker AK, Coffey DS. J Urol; 1998 Dec; 160(6 Pt 2):2381-92. PubMed ID: 9817389 [Abstract] [Full Text] [Related]
6. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. De Marzo AM, Marchi VL, Epstein JI, Nelson WG. Am J Pathol; 1999 Dec; 155(6):1985-92. PubMed ID: 10595928 [Abstract] [Full Text] [Related]
7. Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma. Cordon-Cardo C, Koff A, Drobnjak M, Capodieci P, Osman I, Millard SS, Gaudin PB, Fazzari M, Zhang ZF, Massague J, Scher HI. J Natl Cancer Inst; 1998 Sep 02; 90(17):1284-91. PubMed ID: 9731735 [Abstract] [Full Text] [Related]
8. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade. Guo Y, Sklar GN, Borkowski A, Kyprianou N. Clin Cancer Res; 1997 Dec 02; 3(12 Pt 1):2269-74. PubMed ID: 9815624 [Abstract] [Full Text] [Related]
9. Expression of p27kip1 in prostatic adenocarcinoma. Cheville JC, Lloyd RV, Sebo TJ, Cheng L, Erickson L, Bostwick DG, Lohse CM, Wollan P. Mod Pathol; 1998 Apr 02; 11(4):324-8. PubMed ID: 9578081 [Abstract] [Full Text] [Related]
16. Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Tsihlias J, Kapusta LR, DeBoer G, Morava-Protzner I, Zbieranowski I, Bhattacharya N, Catzavelos GC, Klotz LH, Slingerland JM. Cancer Res; 1998 Feb 01; 58(3):542-8. PubMed ID: 9458103 [Abstract] [Full Text] [Related]
17. Reduced annexin II protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. Yee DS, Narula N, Ramzy I, Boker J, Ahlering TE, Skarecky DW, Ornstein DK. Arch Pathol Lab Med; 2007 Jun 01; 131(6):902-8. PubMed ID: 17550317 [Abstract] [Full Text] [Related]
18. A novel M(r) 32,000 nuclear phosphoprotein is selectively expressed in cells competent for self-renewal. Walensky LD, Coffey DS, Chen TH, Wu TC, Pasternack GR. Cancer Res; 1993 Oct 01; 53(19):4720-6. PubMed ID: 7691403 [Abstract] [Full Text] [Related]